HRP20231254T1 - Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene - Google Patents
Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene Download PDFInfo
- Publication number
- HRP20231254T1 HRP20231254T1 HRP20231254TT HRP20231254T HRP20231254T1 HR P20231254 T1 HRP20231254 T1 HR P20231254T1 HR P20231254T T HRP20231254T T HR P20231254TT HR P20231254 T HRP20231254 T HR P20231254T HR P20231254 T1 HRP20231254 T1 HR P20231254T1
- Authority
- HR
- Croatia
- Prior art keywords
- combination according
- lipid extract
- krill oil
- around
- mussel lipid
- Prior art date
Links
- 229940106134 krill oil Drugs 0.000 title claims 14
- 241000237536 Mytilus edulis Species 0.000 title claims 13
- 150000002632 lipids Chemical class 0.000 title claims 13
- 235000020638 mussel Nutrition 0.000 title claims 13
- 239000000203 mixture Substances 0.000 title claims 3
- 239000002552 dosage form Substances 0.000 claims 7
- 239000003921 oil Substances 0.000 claims 3
- 235000019198 oils Nutrition 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 235000006708 antioxidants Nutrition 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- 208000006820 Arthralgia Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 241001537211 Perna canaliculus Species 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229930003448 Vitamin K Natural products 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 239000002199 base oil Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 235000019168 vitamin K Nutrition 0.000 claims 1
- 239000011712 vitamin K Substances 0.000 claims 1
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 229940046010 vitamin k Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Claims (22)
1. Kombinacija koja sadrži ekstrakt lipida dagnji i ulje krila, pri čemu je kombinacija prilagođena za odvojenu ili istovremenu primjenu, pri čemu se ekstrakt lipida dagnji dobiva od perna canaliculus, i pri čemu je maseni odnos ekstrakta lipida dagnji prema ulju krila u rasponu od 5:95 do 99:1.
2. Kombinacija prema patentnom zahtjevu 1 u obliku kompozicije koja sadrži ekstrakt lipida dagnji i ulje krila.
3. Kombinacija prema patentnom zahtjevu 1 ili 2, pri čemu ulje krila ima sadržaj fosfolipida od najmanje oko 40% m/m ili najmanje oko 50% m/m ili najmanje oko 60% m/m.
4. Kombinacija prema bilo kojem od patentnih zahtjeva 1-3, pri čemu ulje krila ima sadržaj vode od oko 5% m/m ili manje, ili oko 3% m/m ili manje, ili oko 1% m/m ili manje; i/ili
sadržaj otapala za ekstrakciju od oko 5% m/m ili manje, ili oko 3% m/m ili manje, ili oko 1% m/m ili manje.
5. Kombinacija prema bilo kojem od patentnih zahtjeva 1-4, pri čemu je maseni odnos ekstrakta lipida dagnji prema ulju krila u rasponu od oko 5:95 do 95:5, poželjno u rasponu od oko 10:90 do 90:10, kao što je, oko 10:90 ili oko 15:85 ili oko 20:80 ili oko 25:75 ili oko 30:70 ili oko 35:65 ili oko 40:60 ili oko 45:55 ili oko 50:50 ili oko 55:45 ili oko 60:40 ili oko 65:35 ili oko 70:30 ili oko 75:25 ili oko 80:20 ili oko 85:15 ili oko 90:10.
6. Kombinacija prema bilo kojem od patentnih zahtjeva 1-5 u oralnom jediničnom doznom obliku.
7. Kombinacija prema patentnom zahtjevu 6, pri čemu je oralni jedinični dozni oblik meka gel kapsula.
8. Kombinacija prema patentnom zahtjevu 6 ili 7, pri čemu oralni jedinični dozni oblik sadrži od oko 10 mg do oko 1,0 g ekstrakta lipida dagnji; i/ili
od oko 10 mg do oko 1,0 g ulja krila.
9. Kombinacija prema patentnom zahtjevu 8, pri čemu oralni jedinični dozni oblik sadrži
oko 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 150 mg, 200 mg, 250 mg, 300 mg, 350 mg, 400 mg, 450 mg, 500 mg, 550 mg, 600 mg, 650 mg, 700 mg, 750 mg, 800 mg, 850 mg, 900 mg, 950 mg ili oko 1,0 g ekstrakta lipida dagnji; i/ili
oko 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 150 mg, 200 mg, 250 mg, 300 mg, 350 mg, 400 mg, 450 mg, 500 mg, 550 mg, 600 mg, 650 mg, 700 mg, 750 mg, 800 mg, 850 mg, 900 mg, 950 mg ili 1,0 g ulja krila.
10. Kombinacija prema patentnom zahtjevu 9, pri čemu oralni jedinični dozni oblik sadrži od oko 10 mg do oko 500 mg ekstrakta lipida dagnji; i/ili
od oko 10 mg do oko 500 mg ulja krila.
11. Kombinacija prema bilo kojem od patentnih zahtjeva 1-10, pri čemu oralni jedinični dozni oblik sadrži oko 10-500 mg kombinacije ekstrakta lipida dagnji i ulja krila.
12. Kombinacija prema patentnom zahtjevu 11, pri čemu oralni jedinični dozni oblik sadrži oko 50-300 mg kombinacije ekstrakta lipida dagnji i ulja krila.
13. Kombinacija prema bilo kojem od patentnih zahtjeva 1-12, koja dalje sadrži jedan ili više farmaceutski prihvatljivih nosača i/ili aditiva.
14. Kombinacija prema patentnom zahtjevu 13, koja sadrži ulje kao nosač i opcionalno antioksidans.
15. Kombinacija prema patentnom zahtjevu 14, pri čemu ulje kao nosač je maslinovo ulje.
16. Kombinacija prema patentnom zahtjevu 14 ili 15, pri čemu ulje kao nosač sadrži od oko 10% m/m do oko 90% m/m ukupne kompozicije.
17. Kombinacija prema patentnom zahtjevu 14 ili 15, pri čemu je maseni odnos ulja kao nosača prema kombiniranoj količini ekstrakta lipida dagnji i ulja krila od oko 3:1, do oko 1:3.
18. Kombinacija prema patentnom zahtjevu 13, pri čemu je jedan ili više aditiva izabrano od antioksidanasa, vitamina A, vitamina D, vitamina E i vitamina K.
19. Kombinacija prema bilo kojem od patentnih zahtjeva 1-18 koja se sastoji ili se u suštini sastoji od ekstrakta lipida dagnji i ulja krila.
20. Kombinacija prema bilo kojem od patentnih zahtjeva 1-19 za primjenu u liječenju upala kod subjekta.
21. Kombinacija prema bilo kojem od patentnih zahtjeva 1-19 za primjenu u liječenju bola kod subjekta.
22. Kombinacija prema bilo kojem od patentnih zahtjeva 1-19 za primjenu u liječenju bolova u zglobovima ili poboljšanju pokretljivosti zglobova u vezi sa osteoartritisom ili reumatoidnim artritisom kod subjekta.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017905181A AU2017905181A0 (en) | 2017-12-22 | Lipid combinations | |
| EP18892617.4A EP3727404B1 (en) | 2017-12-22 | 2018-12-21 | Compositions comprising mussel lipid extract and krill oil, and their medical applications |
| PCT/IB2018/060482 WO2019123400A1 (en) | 2017-12-22 | 2018-12-21 | Lipid combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20231254T1 true HRP20231254T1 (hr) | 2024-02-02 |
Family
ID=66993218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20231254TT HRP20231254T1 (hr) | 2017-12-22 | 2018-12-21 | Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US11654163B2 (hr) |
| EP (1) | EP3727404B1 (hr) |
| JP (2) | JP2021507872A (hr) |
| KR (1) | KR20200102914A (hr) |
| CN (1) | CN110337300A (hr) |
| AR (1) | AR117943A1 (hr) |
| AU (2) | AU2018392997A1 (hr) |
| BR (1) | BR112020012770A2 (hr) |
| CA (1) | CA3065174A1 (hr) |
| CL (1) | CL2020001649A1 (hr) |
| DK (1) | DK3727404T3 (hr) |
| DO (1) | DOP2020000131A (hr) |
| EA (1) | EA202091551A1 (hr) |
| EC (1) | ECSP20042134A (hr) |
| ES (1) | ES2959633T3 (hr) |
| FI (1) | FI3727404T3 (hr) |
| HR (1) | HRP20231254T1 (hr) |
| HU (1) | HUE064489T2 (hr) |
| IL (1) | IL275583B2 (hr) |
| JO (1) | JOP20200108B1 (hr) |
| LT (1) | LT3727404T (hr) |
| MX (1) | MX2019014252A (hr) |
| NI (1) | NI202000047A (hr) |
| NZ (1) | NZ755776A (hr) |
| PE (1) | PE20211308A1 (hr) |
| PH (1) | PH12020550965A1 (hr) |
| PL (1) | PL3727404T3 (hr) |
| PT (1) | PT3727404T (hr) |
| RS (1) | RS64705B1 (hr) |
| SA (1) | SA520412019B1 (hr) |
| SG (1) | SG11202003935QA (hr) |
| SI (1) | SI3727404T1 (hr) |
| TW (1) | TWI815840B (hr) |
| UA (1) | UA126417C2 (hr) |
| UY (1) | UY38033A (hr) |
| WO (1) | WO2019123400A1 (hr) |
| ZA (1) | ZA202003454B (hr) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN531195A0 (en) | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
| CA2251265A1 (en) | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Process for lipid extraction of aquatic animal tissues producing a dehydrated residue |
| US6596303B1 (en) | 1999-03-22 | 2003-07-22 | Mars Incorporated | Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
| CN1516592A (zh) | 2001-06-18 | 2004-07-28 | �����Ǽ���&������Դ����˾ | 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物 |
| CA2493888C (en) * | 2001-07-27 | 2013-07-16 | Neptune Technologies & Bioressources Inc. | Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| CA2554932A1 (en) | 2004-01-30 | 2005-08-11 | Bionovate Limited | Solvent extraction of lipids such as essential fatty acids |
| GB0411166D0 (en) | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Treatment for asthma and arthritis |
| NZ563125A (en) | 2005-06-03 | 2009-11-27 | Mcfarlane Marketing Aust Pty L | Lipid extract of mussels and method for preparation thereof |
| TW200811280A (en) | 2006-04-20 | 2008-03-01 | Owen John Catchpole | Product and process |
| NZ547429A (en) | 2006-05-24 | 2009-09-25 | Ind Res Ltd | Extraction of highly unsaturated lipids with liquid dimethyl ether |
| WO2008035756A1 (fr) | 2006-09-22 | 2008-03-27 | Heimat Co., Ltd. | Composition anti-angiogénique comportant un extrait ayant une activité anti-angiogénique et une lécithine |
| AU2011213836B2 (en) | 2007-03-28 | 2013-11-14 | Aker Biomarine Antarctic As | Bioeffective krill oil compositions |
| WO2008117062A1 (en) | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Bioeffective krill oil compositions |
| US8557297B2 (en) | 2008-09-12 | 2013-10-15 | Olympic Seafood, As | Method for processing crustaceans and products thereof |
| US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
| US8481072B2 (en) | 2009-07-23 | 2013-07-09 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain |
| NO2493478T3 (hr) | 2009-10-29 | 2018-07-21 | ||
| US8609157B2 (en) | 2009-10-30 | 2013-12-17 | Tharos Ltd. | Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
| US9415035B2 (en) | 2010-09-17 | 2016-08-16 | Maine Natural Health Company, Inc. | Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof |
| US20120231087A1 (en) * | 2011-03-07 | 2012-09-13 | Olympic Seafood | Compositions And Methods for Nutritional Supplementation |
| PT2697345T (pt) | 2011-04-14 | 2016-07-07 | Polar Omega As | Um processo para o isolamento de um fosfolípido |
| US20150005382A1 (en) * | 2011-10-04 | 2015-01-01 | Wake Forest University Health Sciences (WFUHS) | Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies |
| RU2526826C2 (ru) | 2012-10-24 | 2014-08-27 | Николай Владимирович Соловьёв | Композиция для парентерального введения, способ получения и применение композиции |
| GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
| GB201402450D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Liquid phospholipid-containing compositions for preperation of pharmaceuticals |
| KR20160144388A (ko) * | 2014-03-18 | 2016-12-16 | 유.에스. 뉴트라수티칼스, 엘.엘.씨. | 저분자량 히알루론산 및 아스타잔틴을 사용하여 관절 통증을 완화하기 위한 조성물 및 방법 |
| EP3439676B1 (en) * | 2016-04-04 | 2021-06-09 | Omeza LLC | Fish oil topical composition |
| CN105685482A (zh) | 2016-04-21 | 2016-06-22 | 中国海洋大学 | 一种提高石斑鱼稚鱼抗应激能力的微颗粒饲料 |
| CN106306554B (zh) | 2016-08-16 | 2019-10-11 | 中国水产科学研究院黄海水产研究所 | 一种可替代鲜活饵料的凡纳滨对虾亲虾饲料 |
| KR20200096593A (ko) | 2017-12-04 | 2020-08-12 | 림프로스트 테크놀로지스 에이에스 | 갑각류 어획물로부터 단백질 인지질 복합체를 제조하는 방법 |
-
2018
- 2018-12-21 HR HRP20231254TT patent/HRP20231254T1/hr unknown
- 2018-12-21 HU HUE18892617A patent/HUE064489T2/hu unknown
- 2018-12-21 TW TW107146439A patent/TWI815840B/zh active
- 2018-12-21 RS RS20230933A patent/RS64705B1/sr unknown
- 2018-12-21 NZ NZ755776A patent/NZ755776A/en unknown
- 2018-12-21 DK DK18892617.4T patent/DK3727404T3/da active
- 2018-12-21 CN CN201880014073.2A patent/CN110337300A/zh active Pending
- 2018-12-21 UA UAA202004611A patent/UA126417C2/uk unknown
- 2018-12-21 JP JP2019560209A patent/JP2021507872A/ja active Pending
- 2018-12-21 UY UY0001038033A patent/UY38033A/es unknown
- 2018-12-21 FI FIEP18892617.4T patent/FI3727404T3/fi active
- 2018-12-21 MX MX2019014252A patent/MX2019014252A/es unknown
- 2018-12-21 US US16/481,444 patent/US11654163B2/en active Active
- 2018-12-21 KR KR1020197034981A patent/KR20200102914A/ko not_active Application Discontinuation
- 2018-12-21 EA EA202091551A patent/EA202091551A1/ru unknown
- 2018-12-21 AR ARP180103836A patent/AR117943A1/es unknown
- 2018-12-21 CA CA3065174A patent/CA3065174A1/en active Pending
- 2018-12-21 EP EP18892617.4A patent/EP3727404B1/en active Active
- 2018-12-21 SG SG11202003935QA patent/SG11202003935QA/en unknown
- 2018-12-21 PT PT188926174T patent/PT3727404T/pt unknown
- 2018-12-21 JO JOP/2020/0108A patent/JOP20200108B1/ar active
- 2018-12-21 PL PL18892617.4T patent/PL3727404T3/pl unknown
- 2018-12-21 SI SI201830996T patent/SI3727404T1/sl unknown
- 2018-12-21 BR BR112020012770-1A patent/BR112020012770A2/pt unknown
- 2018-12-21 ES ES18892617T patent/ES2959633T3/es active Active
- 2018-12-21 PE PE2020000821A patent/PE20211308A1/es unknown
- 2018-12-21 LT LTEPPCT/IB2018/060482T patent/LT3727404T/lt unknown
- 2018-12-21 IL IL275583A patent/IL275583B2/en unknown
- 2018-12-21 AU AU2018392997A patent/AU2018392997A1/en not_active Abandoned
- 2018-12-21 WO PCT/IB2018/060482 patent/WO2019123400A1/en active Application Filing
-
2020
- 2020-05-21 SA SA520412019A patent/SA520412019B1/ar unknown
- 2020-06-09 ZA ZA2020/03454A patent/ZA202003454B/en unknown
- 2020-06-18 NI NI202000047A patent/NI202000047A/es unknown
- 2020-06-18 CL CL2020001649A patent/CL2020001649A1/es unknown
- 2020-06-22 DO DO2020000131A patent/DOP2020000131A/es unknown
- 2020-06-22 PH PH12020550965A patent/PH12020550965A1/en unknown
- 2020-07-22 EC ECSENADI202042134A patent/ECSP20042134A/es unknown
-
2021
- 2021-07-08 AU AU2021204787A patent/AU2021204787B2/en active Active
-
2023
- 2023-06-06 JP JP2023093106A patent/JP2023113819A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017002939A1 (es) | Composiciones farmacéuticas tópicas | |
| CL2020000747A1 (es) | Formulaciones de niraparib. | |
| PH12017502375A1 (en) | Method of treating inflammation using natural compounds and/or diet | |
| CO2018002394A2 (es) | Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa | |
| MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
| MX2013009007A (es) | Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. | |
| RU2016133688A (ru) | Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли | |
| US10953068B2 (en) | Anti-inflammatory composition for the treatment of acute joint inflammation and a process for preparation thereof | |
| TR201821157T4 (tr) | İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m. | |
| EP3359131A1 (en) | Capsule with internal diaphragm for improved bioavailability | |
| ES2912123T3 (es) | Composiciones útiles para la prevención y/o el tratamiento de la inflamación y el dolor osteoarticular y el daño del cartílago | |
| BR112015019264A8 (pt) | cápsulas para o tratamento de helicobacter pylori e seu uso". | |
| MX2015011255A (es) | Composicion a base de flavonoides para uso farmaceutico, nutricional o cosmetico que tiene accion antioxidante potenciada. | |
| CL2021003291A1 (es) | Mezcla de extractos de plantas para su uso en la prevención y/o tratamiento de enfermedades inflamatorias crónicas del intestino. | |
| RU2015154451A (ru) | Композиция для повышения качества спермы у субъекта мужского пола | |
| HRP20211160T1 (hr) | Kompozicije koje sadrže geraniol i suhi đumbir za uporabu u liječenju sindroma iritabilnog crijeva | |
| Omer et al. | Irritant contact dermatitis caused by Ranunculus kotschyi Boiss in 6 cases | |
| HRP20231254T1 (hr) | Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene | |
| CA2963570A1 (en) | Pain relief formulation and method of treatment | |
| CN108882722A (zh) | 食用油中的按时释放维生素和矿物质 | |
| CL2019000123A1 (es) | Preparaciones de vitaminas que contienen galato de propilo. | |
| CO7310521A2 (es) | Composición farmaceútica que tiene fluidez mejorada, agente medicional, y método para la producción y uso del mismo | |
| DE202013005637U1 (de) | Mittel mit Tocotrienol bei Verbrennungen durch Sonne, radioaktive Strahlung oder Hitze | |
| BR112015020085A2 (pt) | lipídeo que inibe a atividade do canal de nav1.9, composição, e kit | |
| EA201992844A1 (ru) | Новые пероральные составы на основе белиностата |